CN112386639A - Application of golden camellia juice in preparing blue light resistant composition - Google Patents
Application of golden camellia juice in preparing blue light resistant composition Download PDFInfo
- Publication number
- CN112386639A CN112386639A CN202010823616.4A CN202010823616A CN112386639A CN 112386639 A CN112386639 A CN 112386639A CN 202010823616 A CN202010823616 A CN 202010823616A CN 112386639 A CN112386639 A CN 112386639A
- Authority
- CN
- China
- Prior art keywords
- juice
- blue light
- camellia nitidissima
- camellia
- nitidissima
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000011389 fruit/vegetable juice Nutrition 0.000 title claims abstract description 54
- 239000000203 mixture Substances 0.000 title claims abstract description 17
- 235000018597 common camellia Nutrition 0.000 title description 18
- 240000001548 Camellia japonica Species 0.000 title description 15
- 241001328788 Camellia nitidissima Species 0.000 claims abstract description 50
- 230000008832 photodamage Effects 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims description 15
- 230000001590 oxidative effect Effects 0.000 claims description 12
- 210000001626 skin fibroblast Anatomy 0.000 claims description 11
- 241000894007 species Species 0.000 claims description 11
- 239000003642 reactive oxygen metabolite Substances 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 9
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 6
- 229930003944 flavone Natural products 0.000 claims description 6
- 150000002212 flavone derivatives Chemical class 0.000 claims description 6
- 235000011949 flavones Nutrition 0.000 claims description 6
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000000835 fiber Substances 0.000 abstract description 8
- 239000000126 substance Substances 0.000 abstract description 8
- 230000003647 oxidation Effects 0.000 abstract description 4
- 238000007254 oxidation reaction Methods 0.000 abstract description 4
- 239000000243 solution Substances 0.000 description 14
- 238000012360 testing method Methods 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000007800 oxidant agent Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 239000012086 standard solution Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 4
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 4
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 4
- 235000005493 rutin Nutrition 0.000 description 4
- 229960004555 rutoside Drugs 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 241000209507 Camellia Species 0.000 description 3
- 241001657422 Camellia petelotii Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 235000006468 Thea sinensis Nutrition 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 241001122767 Theaceae Species 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000003070 absorption delaying agent Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000007758 minimum essential medium Substances 0.000 description 2
- 229940023488 pill Drugs 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000001099 axilla Anatomy 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229940046011 buccal tablet Drugs 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- -1 nail polishes Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/06—Products with modified nutritive value, e.g. with modified starch content
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/36—Vegetable material
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Nutrition Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Alternative & Traditional Medicine (AREA)
- Toxicology (AREA)
- Medical Informatics (AREA)
- Biochemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Birds (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
Abstract
Use of Camellia nitidissima juice for preparing anti-blue light composition, wherein blue light wavelength is 400 nm to 600 nm. The compositions of the present invention have one or more of the following functions: improving the blue light damage resistance of the skin, improving the blue light damage resistance of skin fiber cells, reducing the generation of active oxidation substances of the skin fiber cells and the like.
Description
Technical Field
The invention relates to golden camellia juice, in particular to application of the golden camellia juice in preparing a blue light resistant composition.
Background
Camellia nitidissima is evergreen shrub or small tree of Camellia (Camellia) of Theaceae. Leaves with broad lanceolate to oblong shapes alternate. Golden flower is single-grown leaves axilla or near-top-grown, has petal meat, has waxy luster, is cup-shaped, pot-shaped or bowl-shaped when being opened, and has a flower diameter of 6 cm; 9-11 petals; the flowering period is 10-12 months. The golden camellia is an excellent garden ornamental flower.
In the year 1984, the camellia chrysantha is listed as a Chinese primary protection plant, and the leaf part of the camellia chrysantha is also made into east tea which is reputed to be international. The compendium of materia medica also describes that it has the medicinal functions of clearing away heat and toxic material, promoting diuresis and removing dampness and stopping bleeding.
Disclosure of Invention
In taiwan patent publication No. 201929891, the inventors have disclosed the use of camellia nitidissima juice for enhancing anti-glycosylation activity and inhibiting the accumulation of cell fat. However, in order to improve the medicinal value of the camellia nitidissima, the inventor continuously researches and develops other applications of related products of the camellia nitidissima.
In view of the above, the present invention provides a use of camellia nitidissima juice for preparing a composition for resisting blue light, wherein the wavelength of the blue light is 400 nanometers (nm) to 600 nanometers (nm).
In one embodiment, the Camellia nitidissima juice is used for improving the skin resistance to blue light damage.
In one embodiment, Camellia nitidissima juice is used for preventing skin fiber cells from being damaged by blue light.
In one embodiment, Camellia nitidissima juice is used to prevent Reactive Oxygen Species (ROS) from exposing skin fibroblasts to blue light.
In one embodiment, Camellia nitidissima juice is used to reduce the production of active oxidizing substances by skin fibroblasts by more than 50%.
In one embodiment, the Camellia nitidissima juice has an effective concentration of 0.25 mg/mL.
In one embodiment, the Camellia nitidissima juice has a total flavone content of 10 mg/g.
In one embodiment, the Camellia nitidissima juice is extracted from leaves of Camellia nitidissima.
In one embodiment, the Camellia nitidissima juice is in powder form.
In summary, Camellia nitidissima juice according to any embodiment of the present invention can be used for preparing a blue light-resistant composition. In other words, the aforementioned composition has one or more of the following functions: improving the blue light damage resistance of the skin, improving the blue light damage resistance of skin fiber cells, reducing the generation of active oxidation substances of the skin fiber cells and the like.
Drawings
FIG. 1 is a histogram of the results of blue light resistance experiment of Camellia nitidissima juice.
Detailed Description
As used herein, the concentration symbol "wt%" generally refers to weight percent concentration, while the concentration symbol "vol%" generally refers to volume percent concentration. As used herein, "Camellia nitidissima" refers generally to the leaves of Camellia nitidissima.
In some embodiments, the Camellia nitidissima juice refers to a product obtained by grinding, extracting, filtering, concentrating, sterilizing, and drying leaves of Camellia nitidissima (Camellia chrysantha). For example, the leaf of camellia nitidissima is cut up, extracted with an extraction solvent to obtain an initial extract, and then the initial extract is filtered to remove impurities, and then concentrated with the filtered initial extract to obtain a concentrated solution. The concentrated solution is then sterilized and the sterilized concentrated solution is spray dried to a powder. The dried powder is golden camellia juice containing effective components.
In some embodiments, the Camellia nitidissima juice can be a commercially available Camellia sinensis extract or Camellia sinensis extract powder. In some embodiments, the Camellia nitidissima juice is extracted by pulverizing Camellia nitidissima (Camellia chrysanthha) of Guangzhou into fragments of about less than 0.5cm, mixing the pulverized Camellia nitidissima with a solvent at a temperature of 80 ± 10 ℃ in a range of 5-20: extracting for 0.5-2 hours at a volume ratio of 1-5 to obtain a crude juice. Wherein the solvent may be water, alcohols, aqueous alcohols, or combinations thereof. Subsequently, the crude juice was cooled to room temperature, and then the crude juice was centrifuged at 5000rpm for 10 minutes and subjected to desludging filtration, and the supernatant was collected. Thereafter, the supernatant was filtered through a 400 mesh (mesh) sieve to obtain a filtrate, and then the filtrate was concentrated under reduced pressure at 55. + -. 10 ℃ to obtain a concentrated product. And then, carrying out spray drying on the concentrated product to obtain golden camellia juice.
In one embodiment, the Camellia nitidissima juice is in powder form. In one embodiment, the Camellia nitidissima juice is an edible grade powder.
In an embodiment, the use of camellia nitidissima juice for the preparation of a composition for resisting blue light, wherein the blue light wavelength is 400 nanometers (nm) to 600 nanometers (nm).
In one embodiment, the Camellia nitidissima juice is used for improving the skin resistance to blue light damage. In one embodiment, Camellia nitidissima juice is used for preventing skin fiber cells from being damaged by blue light. In one embodiment, Camellia nitidissima juice is used to prevent skin fibroblasts from Reactive Oxidative Species (ROS) generated by blue light irradiation.
In one embodiment, Camellia nitidissima juice is used to reduce the production of active oxidizing substances by skin fibroblasts by more than 50%.
In one embodiment, the Camellia nitidissima juice has an effective concentration of 0.25 mg/mL.
In one embodiment, the Camellia nitidissima juice has a total flavone content of 10 mg/g.
In some embodiments, any of the compositions described above can be a pharmaceutical. In other words, the medicine contains the golden camellia juice with effective content.
In some embodiments, the foregoing pharmaceuticals may be manufactured using techniques well known to those skilled in the art into dosage forms suitable for enteral, parenteral (parenterally), oral, or topical (topically) administration.
In some embodiments, the dosage form for enteral or oral administration may be, but is not limited to, a lozenge (tablet), a tablet (troche), a buccal tablet (dosage), a pill (pill), a capsule (capsule), a dispersible powder (dispersible powder) or fine granules (granules), a solution, a suspension (suspension), an emulsion (emulsion), a syrup (syrup), an elixir (elixir), a slurry (syrup), or the like. In some embodiments, the parenteral or topical administration dosage form can be, but is not limited to, an injectable (injection), a sterile powder (sterile powder), an external preparation (external preparation), or the like. In some embodiments, the administration of the injectate can be subcutaneous (subcutaneous), intradermal (intraepithelial injection), or intralesional (intrafocal injection).
In some embodiments, the aforementioned pharmaceutical may comprise a pharmaceutically acceptable carrier (pharmaceutical acceptable carrier) that is widely used in pharmaceutical manufacturing technology. In some embodiments, the pharmaceutically acceptable carrier can be one or more of the following carriers: solvents (solvent), buffers (buffer), emulsifiers (emulsifying), suspending agents (suspending agent), disintegrating agents (disintegrant), disintegrating agents (disintegrating agent), dispersing agents (dispersing agent), binding agents (binding agent), excipients (excipient), stabilizers (stabilizing agent), chelating agents (chelating agent), diluents (diluent), gelling agents (gelling agent), preservatives (preserving), wetting agents (wetting agent), lubricants (lubricating), absorption delaying agents (absorption delaying agent), liposomes (liposome) and the like. The type and amount of carrier selected for use is within the skill of the art in terms of skilled literacy and routine skill. In some embodiments, the solvent as a pharmaceutically acceptable carrier may be water, physiological saline (normal saline), Phosphate Buffered Saline (PBS), or an aqueous solution containing alcohol (aqueous solution).
In some embodiments, any of the foregoing compositions may be an edible composition. In other words, the edible composition comprises a specified content of camellia nitidissima juice. In some embodiments, the aforementioned edible composition may be a food product or food additive (food additive). In some embodiments, the food product may be, but is not limited to: beverages (leafages), fermented foods (fermented foods), bakery products (bakery products), health foods (health foods) and dietary supplements (dietary supplements).
In some embodiments, any of the foregoing compositions may be a cosmetic or a care product. In other words, the cosmetic or care product contains a specified content of the camellia nitidissima juice.
In some embodiments, the cosmetic or care product may be any of the following types: lotions, gels, jellies, mud masks, lotions, creams, lipsticks, foundations, pressed powders, honey powders, make-up removers, facial cleansers, shower gels, shampoos, hair tonics, sun blocks, hand creams, nail polishes, perfumes, essences, and facial masks. In some embodiments, the cosmetic or care product may further comprise an external acceptable ingredient, if desired. In some embodiments, the topical acceptable ingredient can be, for example, an emulsifier, a penetration enhancer, a softener, a solvent, an excipient, an antioxidant, or a combination thereof.
An example is as follows: total flavone content test
A methanol solution of 200. mu.g/mL of Rutin (Rutin) was taken as the initial solution (i.e., containing 2000ppm of Rutin). Then, 0. mu.g/mL, 20. mu.g/mL, 40. mu.g/mL, 60. mu.g/mL, 80. mu.g/mL, and 100. mu.g/mL of a standard solution of rutin were prepared according to the following Table I, and 200. mu.L of each concentration of the standard solution was taken out into a glass tube, respectively. 200 mu L of 5% sodium citrate aqueous solution is added into each glass test tube and is uniformly mixed with the standard solution and is kept stand for 6 minutes, then 200 mu L of 10% aluminum nitrate aqueous solution is added and is uniformly mixed and is kept stand for 6 minutes, 2mL of 4% sodium hydroxide aqueous solution is added and is uniformly mixed, and then 1.4mL of water is added and is uniformly mixed to obtain the standard reaction solution. A standard curve was obtained by taking 200. mu.L of the standard reaction solution into a 96-well plate and measuring the absorbance thereof at 500 nm.
Watch 1
Standard solution (μ g/mL) | 0 | 200 | 400 | 600 | 800 | 1000 |
Initial solution (μ L) | 0 | 200 | 400 | 600 | 800 | 1000 |
Water (mu L) | 1000 | 800 | 600 | 400 | 200 | 0 |
Camellia nitidissima juice powder (purchased from Changsha Ha root Biotechnology Co., Ltd., referred to the composition table comprising 92% Camellia nitidissima juice and 8% maltodextrin) was diluted at a ratio of 1:50 (by weight) to obtain a sample. Samples were taken at 200. mu.L into glass tubes. 200 mu L of 5% sodium citrate aqueous solution is added into each glass test tube and is uniformly mixed with the standard solution and is kept stand for 6 minutes, then 200 mu L of 10% aluminum nitrate aqueous solution is added and is uniformly mixed and is kept stand for 6 minutes, 2mL of 4% sodium hydroxide aqueous solution is added and is uniformly mixed, and then 1.4mL of water is added and is uniformly mixed to obtain the standard reaction solution. 200. mu.L of the standard reaction solution was taken into a 96-well plate, and the absorbance at 500nm was measured.
And then, converting the light absorption value of the reaction solution to be detected into the total flavone content by using a standard curve and an interpolation method. Thus, the content of the total flavone in the obtained golden camellia juice is 10 mg/g.
Example two: test for resistance to blue light damage
Human skin fibroblast CCD-966sk (preservation number BCRC60153) was used for this test. The test uses medium of the type MEM (minimum essential medium) of Earle's balanced salts containing 0.1M non-essential amino acids, 1.5g/L sodium bicarbonate, 0.1M pyruvic acid, and 10% fetal bovine serum (from Gibco) by additional addition.
The sample is prepared by using golden camellia juice powder (purchased from Changsha Ha root biotechnology limited) and a culture medium to obtain a golden camellia extraction solution with the concentration of 0.25mg/mL as a first sample and a golden camellia extraction solution with the concentration of 0.125mg/mL as a second sample.
Fluorescent dye DCFH-DA (purchased from Sigma/SI-D6883-50MG) was formulated in Dimethyl sulfoxide (DMSO) as an active oxidizing substance dye at a concentration of 5MG/ml, which could stain against the active oxidizing substance.
The room temperature for this test is 25. + -. 5 ℃.
First, 2mL of medium was added to each well of a six-well plate, and each well was colonized with 1X 105Human dermal fibroblasts. Next, after culturing at 37 ℃ for 24 hours, the medium was removed. The following groups were subjected to duplicate tests and their rounded average values were taken.
Blank group: 0.625. mu.L of medium per well was added and incubated at 37 ℃ for 1 hour, after which 2. mu.L of the active oxidizing substance stain per well was added and allowed to stain for 15 minutes, and after 15 minutes, incubated in the dark at room temperature for 15 minutes.
Control group: after 0.625. mu.L of the medium was added per well and incubated at 37 ℃ for 1 hour, 2. mu.L of the active oxidizing substance dye was added per well to stain for 15 minutes, and after 15 minutes, the wells were placed in a blue light box at room temperature and irradiated with blue light (mainly at 500 nm) for 15 minutes.
Experiment group one: 0.625. mu.L of the above-mentioned sample I was added per well and incubated at 37 ℃ for 1 hour, after which 2. mu.L of the active oxidizing substance stain was added per well and allowed to stain for 15 minutes, after which it was placed in a blue light box at room temperature for 15 minutes under blue light irradiation.
Experiment group two: 0.625. mu.L of the above sample two was added per well and incubated at 37 ℃ for 1 hour, after which 2. mu.L of the active oxidizing substance stain was added per well and allowed to stain for 15 minutes, after which it was placed in a blue light box at room temperature for 15 minutes under blue light irradiation.
Then, each of the above groups was washed twice with 1-fold concentration of PBS buffer (purchased from Gibco), and then reacted for 5 minutes in the absence of light after adding 200ml of trypsin, respectively. The reacted groups are transferred to a 15ml test tube and centrifuged at 400 Xg for 10 minutes, the supernatant in the test tube is removed, then the cells in the test tube are washed once with PBS buffer solution with the concentration of 1 times, then the test tube groups are centrifuged at 400 Xg for 10 minutes again, the supernatant in each group is removed, then 1ml of PBS buffer solution with the concentration of 1 times is added to precipitate the cells in the test tube, finally the fluorescence signals of each group at the excitation wavelength of 450-490 nm and the radiation wavelength of 510-550 nm are detected by a Flow Cytometer (BD Accuri C6 Plus Flow Cytometer 660517) to quantify the content of the reactive oxygen species in the cells, and the proportion of the number of the cells highly expressed by the reactive oxygen species in the cells to the original number is obtained as the relative production amount of the Reactive Oxygen Species (ROS).
The results are shown in Table II below, where the values in Table II are the relative active oxidizing species production, expressed as% calculated by the algorithm in the flow cytometer.
Watch two
Relative amount of Reactive Oxidizing Species (ROS) produced | |
Blank group | 3% |
Control group | 42% |
Experiment set 1 | 18% |
Experiment group two | 27% |
In this case, the determination of whether statistically significant differences between the two sample populations are observed using Excel software is shown in FIG. 1 (in the figure, "x" represents p values less than 0.05, p values less than 0.01, and "x" represents p values less than 0.001. when "x" is more, the statistical differences are more significant).
Refer to fig. 1. The human skin fibroblasts in the blank group were not irradiated with blue light, which means that they were produced in a relative amount of 3% of active oxidative substances under normal physiological metabolic conditions. The human skin fiber cells of the control group produced up to 42% of the relative active oxidative species after 15 minutes of blue light exposure. It is known that blue light significantly promotes the production of active oxidizing substances by human skin fibroblasts, so that the human skin can be greatly damaged.
Reference is continued to fig. 1. The human skin fiber cells of the second experimental group produced 27% of the active oxidative species after being treated with the gold camellia sap at a concentration of 0.125 mg/mL. The amount of active oxidized species produced in the second experimental group was reduced by 15% compared to the amount of active oxidized species produced in the control group. The experimental result shows that the golden camellia juice with the concentration of 0.125mg/mL can obviously prevent the generation of active oxidation substances.
Whereas the human skin fibroblasts of the experimental group one produced 18% of the relative active oxidized species after being treated with the camellia sinensis juice at a concentration of 0.25 mg/mL. The active oxidizing species production in the experimental group was reduced by up to 24% compared to the relative active oxidizing species production in the control group. The experimental result shows that the golden camellia juice with the concentration of 0.25mg/mL can obviously prevent the generation of active oxidation substances.
The present invention is capable of other embodiments, and various changes and modifications may be made by one skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.
Claims (9)
1. Use of Camellia nitidissima juice for the preparation of a composition for the treatment of blue light, wherein the blue light has a wavelength of 400 nm to 600 nm.
2. The use of claim 1, wherein the Camellia nitidissima juice is used to improve the skin's resistance to blue light damage.
3. The use of claim 2, wherein the Camellia nitidissima juice is used to prevent blue light damage to skin fibroblasts.
4. The use of claim 3, wherein the Camellia nitidissima juice is used to prevent Reactive Oxygen Species (ROS) in skin fibroblasts from exposure to blue light.
5. The use of camellia nitidissima juice according to claim 4, wherein the camellia nitidissima juice is used to reduce the production of the active oxidizing species by more than 24% of skin fibroblasts.
6. The use according to any one of claims 1 to 5, wherein the Camellia nitidissima juice is present in an effective concentration of 0.25 mg/mL.
7. Use according to any one of claims 1 to 5, wherein the Camellia nitidissima juice has a total flavone content of 10 mg/g.
8. The use according to claim 1, wherein the Camellia nitidissima juice is obtained by extraction of the leaves of Camellia nitidissima.
9. The use according to claim 1, wherein the Camellia nitidissima juice is in powder form.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962886702P | 2019-08-14 | 2019-08-14 | |
US62/886,702 | 2019-08-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112386639A true CN112386639A (en) | 2021-02-23 |
Family
ID=74596191
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010823616.4A Pending CN112386639A (en) | 2019-08-14 | 2020-08-14 | Application of golden camellia juice in preparing blue light resistant composition |
CN202010822825.7A Pending CN112386621A (en) | 2019-08-14 | 2020-08-14 | Application of broadleaf holly leaf juice |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010822825.7A Pending CN112386621A (en) | 2019-08-14 | 2020-08-14 | Application of broadleaf holly leaf juice |
Country Status (2)
Country | Link |
---|---|
CN (2) | CN112386639A (en) |
TW (2) | TWI747444B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI783823B (en) * | 2021-12-14 | 2022-11-11 | 健茂生物科技股份有限公司 | Production method of composition with anti-blu ray protective capability |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101564372A (en) * | 2009-05-31 | 2009-10-28 | 上海自然堂生物科技有限公司 | Camellia chrysantha additive for skin-care and washing articles |
CN104800137A (en) * | 2015-05-22 | 2015-07-29 | 大连赛姆生物工程技术有限公司 | Application of camellia nitidissima Chi flower extract, moisturizing and skin caring composition and preparation method thereof |
CN106726889A (en) * | 2016-12-02 | 2017-05-31 | 广西中港高科国宝金花茶产业有限公司 | The extracting method of Camellia nitidissima active ingredient and prepare the purposes of health products |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006075865A1 (en) * | 2005-01-11 | 2006-07-20 | Se Young Chung | Skin-condition improving composition comprising vaccinium uliginosum extract and method for preparation thereof |
CN109303748A (en) * | 2018-12-18 | 2019-02-05 | 广州丽丰化妆品制造有限公司 | Natural plant sun composition and its preparation method and the application in sunscreen cosmetic |
-
2020
- 2020-08-14 CN CN202010823616.4A patent/CN112386639A/en active Pending
- 2020-08-14 TW TW109127830A patent/TWI747444B/en active
- 2020-08-14 TW TW109127838A patent/TWI809300B/en active
- 2020-08-14 CN CN202010822825.7A patent/CN112386621A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101564372A (en) * | 2009-05-31 | 2009-10-28 | 上海自然堂生物科技有限公司 | Camellia chrysantha additive for skin-care and washing articles |
CN104800137A (en) * | 2015-05-22 | 2015-07-29 | 大连赛姆生物工程技术有限公司 | Application of camellia nitidissima Chi flower extract, moisturizing and skin caring composition and preparation method thereof |
CN106726889A (en) * | 2016-12-02 | 2017-05-31 | 广西中港高科国宝金花茶产业有限公司 | The extracting method of Camellia nitidissima active ingredient and prepare the purposes of health products |
Non-Patent Citations (1)
Title |
---|
许锐林,等: ""蓝光危害及抗蓝光技术在化妆品中的应用概况", 《香料香精化妆品》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI783823B (en) * | 2021-12-14 | 2022-11-11 | 健茂生物科技股份有限公司 | Production method of composition with anti-blu ray protective capability |
Also Published As
Publication number | Publication date |
---|---|
CN112386621A (en) | 2021-02-23 |
TWI809300B (en) | 2023-07-21 |
TW202106320A (en) | 2021-02-16 |
TWI747444B (en) | 2021-11-21 |
TW202106327A (en) | 2021-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2021502953A (en) | Cosmetic composition for skin whitening and wrinkle improvement containing Centella asiatica extract as an active ingredient | |
KR101402550B1 (en) | Antioxidizing Functional Cosmetic Compositions for Containing Extracted/Fermented Dendropanax morbifera Products and Functional Cosmetics Produced Thereby | |
KR20130074983A (en) | Composition of preservatives for cosmetic and cosmetic composition comprising the same | |
JP2021502396A (en) | Dahlia composition, powder of dahlia composition, cosmetic composition and method for producing the same | |
JP2011016760A (en) | Skin care external preparation, oral agent, moisturizing agent, anti-aging agent, bleaching agent, and anti-oxidizing agent containing bulb of lilium plant and/or callus extract as effective ingredient | |
WO2008029877A1 (en) | Anti-aging agent, skin-whitening agent, anti-oxidative agent, and anti-inflammatory agent | |
JP5557414B2 (en) | Moisturizer, cell activator, and whitening agent | |
CN102321144A (en) | Method for extracting ursolic acid from red jujube | |
KR20100121352A (en) | A composition comprising complex crude drug extract for anti-aging and improvement of skin | |
KR102016062B1 (en) | Callus extracts from Citrus junos Siebold ex Tanaka and Pyrus pyrifolia Nakai with Whitening and Anti-wrinkle effect | |
CN112386639A (en) | Application of golden camellia juice in preparing blue light resistant composition | |
KR20220112447A (en) | Composition for improving skin, comprising Elaeaqnus macrophylla Extract as effective components, Cosmetic composition and Food functional composition including the same | |
KR101954275B1 (en) | Cosmetic compositions containing complex extract of gold kiwi peel and dragon fruit peel, and method manufacturing the same | |
KR20210144725A (en) | Anti-aging, antioxidant, anti-inflammatory and whitening agents, and cosmetics | |
JP4460420B2 (en) | Collagen production promoter | |
JP2005281205A (en) | Macrophage activator | |
KR20200057126A (en) | Composition for Regenerating Skin and Enhancing Hair Growth Comprising Apigenin | |
JP5062980B2 (en) | Moisturizer, collagen production promoter, whitening agent, antioxidant, and vascular endothelial growth factor production promoter | |
KR102198589B1 (en) | Whitening cosmetic composition containing Rhodiola rosea, Selaginella tamariscina, Celosia cristata and Artemisia princeps complex extract and phytol | |
KR102154139B1 (en) | Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract | |
KR20180085106A (en) | Cosmetic composition containing the complex extracts of Hibiscus Esculentus, Momordica Charantia and Morinda Citrifolia | |
KR101822043B1 (en) | Cosmetic Compositions Containing complex Extracts of Nymphaea Caerulea and Cetraria islandica | |
JP4748962B2 (en) | Moisturizer, cell activator, whitening agent, and antioxidant | |
KR102503787B1 (en) | Mixed mucilage extract comprising moroheiya and dragon fruit peel and cosmetic composisiton comprising the same | |
JP4334956B2 (en) | Cell activators, whitening agents, and antioxidants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |